Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review
10.1016/j.biopha.2023.114985 · doi-reference
Remodeling the gut ecosystem and its mechanism: natural products in the treatment of ulcerative colitis via regulating gut microbiota and metabolites
10.1016/j.intimp.2026.116378 · doi-reference
Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia
10.1080/08880018.2016.1276235 · doi-reference
The role of inflammasomes in human diseases and their potential as therapeutic targets
10.1038/s41392-023-01687-y · doi-reference
Next-generation sequencing: insights to advance clinical investigations of the microbiome
10.1172/jci154944 · doi-reference
Interactions between gut microbiota and acute childhood leukemia
10.3389/fmicb.2019.01300 · doi-reference
Intestinal mucositis, systemic inflammation and bloodstream infections following high-dose methotrexate treatment in childhood acute lymphoblastic leukaemia: comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol
10.1002/ijc.35136 · doi-reference
Microbial metagenomic shifts in children with acute lymphoblastic leukaemia during induction therapy and predictive biomarkers for infection
10.1186/s12941-024-00717-z · doi-reference
Reading and conducting instrumental variable studies: guide, glossary, and checklist
10.1136/bmj-2023-078093 · doi-reference
Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial
10.1016/s2352-4642(26)00039-8 · doi-reference
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut
10.1086/599346 · doi-reference
Infectious complications during early treatment of childhood acute lymphoblastic leukemia-a comparison between the ALLTogether and NOPHO ALL-2008 protocols
10.1002/pbc.32120 · doi-reference
ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study
10.1038/s41416-025-02958-x · doi-reference
10.1186/s12885-022-09522-3
10.1186/s12885-022-09522-3 · doi-reference
Striking a balance: how the gut microbiome shapes the fate of intestinal CD4+ T cells
10.1093/discim/kyaf020 · doi-reference
The Integrative Human Microbiome Project
10.1038/s41586-019-1238-8 · doi-reference
Effects of high-inorganic-phosphorus diet on intestinal mucosal injury and immune alteration in mice
10.3390/nu18101590 · doi-reference
The gut connection: a narrative review on the in-depth analysis of gut microbiota and metabolites in depression
10.2174/0127724328332998250118182255 · doi-reference
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
10.3389/fimmu.2023.1127743 · doi-reference
Temporal development of the gut microbiome in early childhood from the TEDDY study
10.1038/s41586-018-0617-x · doi-reference
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
10.1038/s41591-023-02234-6 · doi-reference
Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia
10.1182/bloodadvances.2024013986 · doi-reference
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
10.1038/s41591-022-01702-9 · doi-reference
Relapsed acute lymphoblastic leukemia
10.1007/s12098-023-04635-4 · doi-reference
Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
10.1016/j.cmi.2016.11.001 · doi-reference
Gut microbiome immaturity and childhood acute lymphoblastic leukaemia
10.1038/s41568-023-00584-4 · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · doi-reference
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
10.1038/s41523-024-00707-6 · doi-reference
The microbiome in childhood acute lymphoblastic leukemia
10.3390/cancers13194947 · doi-reference
Distinct effects of a dairy probiotic drink and physical exercise on gut microbiota in pediatric acute lymphoblastic leukemia patients in remission: a randomized clinical trial
10.3389/fmicb.2026.1791192 · doi-reference
Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients
10.1128/jcm.00161-21 · doi-reference
Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis
10.1080/19490976.2020.1870402 · doi-reference
Recent advances in lipopolysaccharide recognition systems
10.3390/ijms21020379 · doi-reference
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
10.1182/blood.2023020026 · doi-reference
Microbiota predict infections and acute graft-versus-host disease after pediatric allogeneic hematopoietic stem cell transplantation
10.1093/infdis/jiad190 · doi-reference
Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage
10.1200/go.21.00266 · doi-reference
Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota
10.3389/fcimb.2020.558799 · doi-reference
Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome
10.1038/s41588-021-00968-y · doi-reference
Microbial tryptophan catabolites in health and disease
10.1038/s41467-018-05470-4 · doi-reference
